[Drug-induced agranulocytosis: role of the myelogram and biological tests].
Jobert
E
E
Service d'hématologie biologique, CHU Nancy, 54035 Nancy cedex.
Latger-Cannard
V
V
Lesesve
J F
JF
Buisine
J
J
Feugier
P
P
Tréchot
P
P
Lecompte
T
T
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000380:Agranulocytosis / Q000097:blood / Q000139:chemically induced* / Q000175:diagnosis* / Q000188:drug therapy; D000900:Anti-Bacterial Agents; D000935:Antifungal Agents / Q000009:adverse effects*; D001772:Blood Cell Count; D001853:Bone Marrow / Q000473:pathology*; D002177:Candidiasis / Q000188:drug therapy; D004359:Drug Therapy, Combination / Q000009:adverse effects*; D005260:Female; D000069585:Filgrastim; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D006801:Humans; D007958:Leukocyte Count; D008297:Male; D011994:Recombinant Proteins
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D000069585:Filgrastim